KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,528,530 | -40.5% | 1,140,694 | -20.5% | 0.01% | -42.1% |
| Q2 2023 | $2,569,893 | -53.2% | 1,435,694 | -6.5% | 0.02% | -50.0% |
| Q1 2023 | $5,496,142 | +5.3% | 1,535,026 | 0.0% | 0.04% | +8.6% |
| Q4 2022 | $5,218,844 | -28.4% | 1,535,026 | +15.0% | 0.04% | -31.4% |
| Q3 2022 | $7,290,000 | +30.8% | 1,335,026 | +8.0% | 0.05% | +10.9% |
| Q2 2022 | $5,572,000 | -43.4% | 1,235,724 | -7.4% | 0.05% | -31.3% |
| Q1 2022 | $9,839,000 | +74.4% | 1,335,026 | +52.1% | 0.07% | +86.1% |
| Q4 2021 | $5,643,000 | +35.1% | 877,668 | +22.3% | 0.04% | +28.6% |
| Q3 2021 | $4,176,000 | -43.6% | 717,668 | 0.0% | 0.03% | -45.1% |
| Q2 2021 | $7,406,000 | -47.7% | 717,668 | -24.6% | 0.05% | -56.8% |
| Q1 2021 | $14,149,000 | -4.0% | 951,574 | -0.0% | 0.12% | +0.9% |
| Q4 2020 | $14,731,000 | +92.8% | 951,578 | +81.8% | 0.12% | +62.5% |
| Q3 2020 | $7,641,000 | +55.5% | 523,370 | +101.7% | 0.07% | +38.5% |
| Q2 2020 | $4,914,000 | -69.0% | 259,463 | -69.3% | 0.05% | -70.5% |
| Q1 2020 | $15,842,000 | -2.2% | 845,366 | +0.0% | 0.18% | +1.1% |
| Q4 2019 | $16,205,000 | +57.1% | 845,334 | -21.2% | 0.17% | +27.0% |
| Q3 2019 | $10,315,000 | -11.2% | 1,072,228 | -44.9% | 0.14% | -5.5% |
| Q2 2019 | $11,610,000 | +6.5% | 1,946,778 | +4.3% | 0.14% | +4.3% |
| Q1 2019 | $10,902,000 | -35.1% | 1,866,778 | +4.1% | 0.14% | -46.1% |
| Q4 2018 | $16,795,000 | -9.1% | 1,792,544 | +65.1% | 0.26% | +4.9% |
| Q3 2018 | $18,486,000 | +121.2% | 1,085,500 | +120.6% | 0.25% | +86.4% |
| Q2 2018 | $8,359,000 | +183.1% | 492,000 | +123.6% | 0.13% | +164.0% |
| Q1 2018 | $2,953,000 | -23.7% | 220,000 | -45.4% | 0.05% | -25.4% |
| Q4 2017 | $3,869,000 | -30.9% | 403,000 | -21.0% | 0.07% | -31.6% |
| Q3 2017 | $5,600,000 | +41.3% | 510,000 | +16.4% | 0.10% | +32.4% |
| Q2 2017 | $3,964,000 | +79.4% | 438,000 | +154.7% | 0.07% | +72.1% |
| Q1 2017 | $2,209,000 | -39.7% | 172,000 | -55.9% | 0.04% | -48.8% |
| Q4 2016 | $3,666,000 | +39.6% | 390,000 | +44.4% | 0.08% | +33.3% |
| Q3 2016 | $2,627,000 | +144.6% | 270,000 | +68.8% | 0.06% | +125.0% |
| Q2 2016 | $1,074,000 | -35.3% | 160,000 | -14.4% | 0.03% | -31.7% |
| Q1 2016 | $1,659,000 | -34.5% | 187,000 | -2.1% | 0.04% | -39.7% |
| Q4 2015 | $2,532,000 | +49.3% | 191,100 | +18.6% | 0.07% | +61.9% |
| Q3 2015 | $1,696,000 | -53.1% | 161,100 | +21.1% | 0.04% | -44.0% |
| Q2 2015 | $3,619,000 | -56.1% | 133,000 | -50.6% | 0.08% | -54.8% |
| Q1 2015 | $8,236,000 | -26.2% | 269,000 | -9.7% | 0.17% | -28.8% |
| Q4 2014 | $11,154,000 | – | 298,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |